IRulya Therapeutics (IRLA) Total Liabilities (Quarterly): 15.51M

IRulya Therapeutics, Inc. (IRLA)

32.95 +1.33 (+4.21%) USD | NASDAQ | Oct 30, 16:00

33.50 +0.55 (+1.67%) After-Hours: 20:00

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.

Date	Value
June 30, 2026	15.51M
March 31, 2026	10.95M
December 31, 2025	129.35M
September 30, 2025	108.84M
June 30, 2025	105.47M
March 31, 2025	88.51M
December 31, 2024	96.01M
September 30, 2024	81.59M
June 30, 2024	87.86M
March 31, 2024	85.12M
December 31, 2023	95.12M
September 30, 2023	2.253M
June 30, 2023	1.952M
March 31, 2023	3.115M
December 31, 2022	4.352M

Date	Value
September 30, 2022	5.246M
June 30, 2022	6.331M
March 31, 2022	9.75M
December 31, 2021	14.64M
September 30, 2021	14.76M
June 30, 2021	19.31M
March 31, 2021	18.04M
December 31, 2020	17.20M
September 30, 2020	16.65M
June 30, 2020	13.74M
March 31, 2020	13.16M
December 31, 2019	8.892M
September 30, 2019	6.127M
June 30, 2019	7.025M
March 31, 2019	4.485M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks